Fabrice PIROT
Equipe : Groupe Rockfeller
Courriel : fabrice.pirot@univ-lyon1.fr
Téléphone : +33(0)4-78-78-56-86
Statut : Professeur
13 publications au total. Seules les 5 dernières années sont affichées
2024
13. Comparing efficacy and safety of in-house gemcitabine to mitomycin for bladder instillation in intermediate-risk NMIBC.
Abou Chaaya C, Ourfali S, Marchand C, Merienne C, Ruffion A, Brouzes H, Abid N, Pirot F, Colombel M
(2024) Fr J Urol 34 :102699-102699
12. Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations.
Jambon A, Forat M, Marchand C, Morel C, Merienne C, Filali S, Pirot F
(2024) Eur J Hosp Pharm :
11. Rationalisation of the purification process for a phage active pharmaceutical ingredient.
Lapras B, Marchand C, Merienne C, Medina M, Kolenda C, Laurent F, Pirot F
(2024) Eur J Pharm Biopharm 203 :114438-114438
2023
10. Effects of pro-inflammatory cytokines and cell interactions on cell area and cytoskeleton of rheumatoid arthritis synoviocytes and immune cells.
Filali S, Noack M, Géloën A, Pirot F, Miossec P
(2023) Eur J Cell Biol 102 :151303-151303
9. Predictive stability, novel HPLC-MS analysis and semi-automatic compounding process for the emergency implementation of a production line of pancuronium in injectable solution.
Merienne C, Filali S, Marchand C, Lapras B, Paillet C, Pirot F
(2023) Eur J Pharm Sci 187 :106464-106464
2017
8. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.
Boisgard As, Lamrayah M, Dzikowski M, Salmon D, Kirilov P, Primard C, Pirot F, Fromy B, Verrier B
(2017) Eur J Pharm Biopharm 116 :51-60
7. Comparison of four different fuller's earth formulations in skin decontamination.
Roul A, Le Ca, Gustin Mp, Clavaud E, Verrier B, Pirot F, Falson F
(2017) J Appl Toxicol :
2016
6. Percutaneous absorption of benzophenone-3 loaded lipid nanoparticles and polymeric nanocapsules: A comparative study.
Gilbert E, Roussel L, Serre C, Sandouk R, Salmon D, Kirilov P, Haftek M, Falson F, Pirot F
(2016) Int J Pharm 504 :48-58
5. Ex-Vivo percutaneous absorption of enrofloxacin: Comparison of LMOG organogel vs. pentravan cream.
Kirilov P, Tran Vh, Ducrotte-tassel A, Salvi Jp, Perrot S, Haftek M, Boulieu R, Pirot F
(2016) Int J Pharm 498 :170-7
2015
4. Deleterious effects of skin freezing contribute to variable outcomes of the predictive drug permeation studies using hydrophilic molecules.
Abdayem R, Roussel L, Zaman N, Pirot F, Gilbert E, Haftek M
(2015) Exp Dermatol 24 :972-4
3. Measurement, analysis and prediction of topical UV filter bioavailability.
Roussel L, Gilbert E, Salmon D, Serre C, Gabard B, Haftek M, Maibach Hi, Pirot F
(2015) Int J Pharm 478 :804-10
2. New easy handling and sampling device for bioavailability screening of topical formulations.
Salmon D, Gilbert E, Gioia B, Haftek M, Pivot C, Verrier B, Pirot F
(2015) Eur J Dermatol 25 Suppl 1 :23-9
1. [Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study].
Tall Ml, Lehmann S, Diouf E, Gerard C, Filali S, Gabelle A, Hirtz C, Gabert L, Sauvinet V, Pirot F, Pivot C
(2015) Ann Pharm Fr 73 :43-59
